Dipal Doshi, President and CEO at Entrada Therapeutics, Inc. (TRDA), sold 7,827 shares at $15.12 ($118K) on 2022-09-21, disclosed to the SEC on 2022-09-23.
Open-market sale of $118k TRDA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.12 | 3,402 | $51K | 43.5% |
| 2 | $15.12 | 3,402 | $51K | 43.5% |
| 3 | $15.07 | 1,023 | $15K | 13.0% |
| Total | $15.11 avg | 7,827 | $118K | 100% |
| Filing → |
| TRDA | SELL | 2024-05-20 | $45K | — | Filing → |
| TRDA | SELL | 2024-02-20 | $15K | — | Filing → |
| TRDA | SELL | 2024-01-18 | $16K | — | Filing → |